Designing Longevity
Skip to main content

Kisspeptin

Kisspeptin is a peptide involved in reproductive hormone signaling. Human studies of kisspeptin-54 have examined short-term sexual responses and egg maturation during IVF. Both uses remain investigational.

Sources reviewed November 13, 2026 · How we work

Sexual desire research in premenopausal women

In a randomized trial, 32 premenopausal women with distressing low sexual desire completed visits with kisspeptin-54 and with placebo. The study found changes in brain responses to sexual and attraction cues during the visit. Longer studies would be needed to establish sustained improvement in everyday sexual desire or distress.

Sources for this section

Egg-maturation research during IVF

A phase 2 study tested kisspeptin-54 as a trigger for final egg maturation before retrieval in 60 patients at high risk of an excessive response to ovarian stimulation. The study assessed egg maturation in a monitored IVF cycle. It leaves open how the approach compares with standard triggers for live births in broader patient groups.

Sources for this section

What the FDA says about kisspeptin-10

Kisspeptin-10 is a shorter peptide than the kisspeptin-54 used in these two studies. FDA identifies possible safety risks with compounded kisspeptin-10, including immune reactions and difficulties assessing impurities. The findings above apply to the form and settings the studies actually used.

Sources for this section
Explore Sexual Health & Fertility